Last Updated: 13/03/2024
BioMalPar XVI (EMBL Conference), Brittany Riggle: Targeting CD8+ T cells – A Paradigm Shift in Treating Cerebral Malaria?
Collaborator(s): National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), United States
Published: 19/05/2020
In collaboration with BioMalPar XVI (EMBL Conference) and session presenters, MESA brings you this webcast from the Virtual Biology and Pathology of the Malaria Parasite, May 2020.
Title: “Targeting CD8+ T cells – A Paradigm Shift in Treating Cerebral Malaria?”
Author: Brittany Riggle – National Institute of Allergy and Infectious Diseases, USA
May 19, 2020, 14:50 PM – 15:20 PM, Keynote lecture
Related Resources
